Step right up ... to better brain function and a whole lot more
Everybody wants to sidestep health problems, but sometimes you have to step up and walk forward to avoid serious medical conditions such as Parkinson's disease, dementia and stroke. That's the conclusion of a study that tracked 22,000 adults ages 40 and older for a year and then checked their medical records over the next five years.
Turns out that participants who got less than 5,000 steps a day were 80% more likely to develop dementia, Parkinson's or have a stroke than those averaging 12,000 or more.
The folks who walked the most also had lower blood pressure and BMI and were less likely to have diabetes or depression. In fact, while 8.6% of people getting less than 4,800 steps a day reported depression, only about 3% of the folks getting 12,000 steps a day did. And 5.6% of the least active folks had diabetes, while only 2% of the most active did. As for blood pressure, it was 13.4% versus 9.2%.
Now, 12,000 steps or step equivalents (Google "Suffolk Step-Conversion Chart") may seem like a lot, but you don't have to do them all at once, and you can build up to it over time! Take a 20-minute walk before starting your workday. Get in another 20-30-minute walk during lunch. And have a long walk after work or dinner or go to the gym (stationary bicycling at a moderate pace is equivalent to 170 steps per minute -- 5,100 in half an hour).
For help creating and sticking to your walking routine, check out the AI coaching program (with yours truly) at 4YOUngevity.com.
Health pioneer Michael Roizen, M.D., is chief wellness officer emeritus at the Cleveland Clinic and author of four No. 1 New York Times bestsellers. Check out his latest, "The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow," and find out more at www.4YOUngevity.com. Email your health and wellness questions to Dr. Mike at drmikerealage@gmail.com.
(c)2026 Michael Roizen, M.D.
Distributed by King Features Syndicate, Inc.
(c) 2026 Michael Roizen, M.D. Distributed by King Features Syndicate, Inc.








Comments